Pregnancy outcomes among African-American patients with systemic lupus erythematosus compared with controls

Lupus Science and Medicine

Volumn 1, Issue 1, 2014, Pages

  Barnado, April ^a   Wheless, Lee ^a   Meyer, Anna K ^a   Gilkeson, Gary S ^a   Kamen, Diane L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA;

ADULT; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMIC LUPUS ERYTHEMATOSUS; UNEMPLOYMENT;

EID: 84949225363     PISSN: None     EISSN: 20538790     Source Type: Journal    
DOI: 10.1136/lupus-2014-000020     Document Type: Article

References (38)

1. Alarcón GS, McGwin G Jr, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 2001;45:191-202. Erratum in: Arthritis Rheum 2001;45:306.
2. Alarcón GS, Roseman J, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998;41:1173-80.
3. Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: A prospective study of the Hopkins Lupus Cohort. J Rheumatol 1992;19:1559-65.
4. Dooley MA, Hogan S, Jennette C, et al. Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network. Kidney Int 1997;51:1188-95.
5. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med 1990;150:849-53.
6. Petri M, Allbritton J. Fetal outcome of lupus pregnancy: A retrospective case-control study of the Hopkins Lupus Cohort. J Rheumtol 1993;20:650-6.
7. Dhar JP, Essenmacher LM, Ager JW, et al. Pregnancy outcomes before and after a diagnosis of systemic lupus erythematosus. Am J Obstet Gynecol 2005;193:1444-55.
8. Andrade R, Sanchez ML, Alarcón GS, et al. Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI). Clin Exp Rheumatol 2008;26:268-73.
9. Hardy CJ, Palmer BP, Morton SJ, et al. Pregnancy outcome and family size in systemic lupus erythematosus: A case-control study. Rheumatology (Oxford) 1999;38:559-63.
10. Nili F, McLeod L, O'Connell C, et al. Maternal and neonatal outcomes in pregnancies complicated by systemic lupus erythematosus: A population-based study. J Obstet Gynaecol Can 2013;35:323-28.
11. Cortés-Hernández J, Ordi-Ros J, Paredes F, et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: A prospective study of 103 pregnancies. Rheumatology 2002;41: 643-50.
12. Chakravarty EF, Colón I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 2005;192:1897-904.
13. Clowse ME, Jamison M, Myers E, et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008;199:127.e1-6.
14. Clowse ME. Lupus activity in pregnancy. Rheum Dis Clin North Am 2007;33:237-52. [Review]
15. McLean DC Jr, Spruill I, Argyropoulos G, et al. Mitochondrial DNA (mtDNA) haplotypes reveal maternal population genetic affinities of Sea Island Gullah-speaking African Americans. Am J Phys Anthropol 2005;127:427-38.
16. Parra EJ, Kittles RA, Argyropoulos G, et al. Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. Am J Phys Anthropol 2001;114:18-29.
17. Kamen DL, Barron M, Parker TM, et al. Autoantibody prevalence and lupus characteristics in a unique African American population. Arthritis Rheum 2008;58:1237-47.
18. Pollitzer WS. The Gullah people and their African heritage. University of Georgia Press, 1999.
19. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
20. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
21. Frøen JF, Gordijn SJ, Abdel-Aleem H, et al. Making stillbirths count, making numbers talk-issues in data collection for stillbirths. BMC Pregnancy Childbirth 2009;9:58.
22. Gladman DD, Goldsmith CH, Urowitz MB, et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000;27:373-6.
23. Lazaro D. Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment. Drugs Aging 2007;24:701-15.
24. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus. NEJM 2003;349:1526-33.
25. Carp HJA, Selmi C, Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. J Autoimmun 2012;38:J266-74. [Review]
26. Lockshin MD, Kim M, Laskin CA, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 2012;64:2311-18.
27. Smyth A, Oliveira GH, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 2010;5:2060-8. [Review]
28. do Prado AD, Piovesan DM, Staub HL, et al. Association of anticardiolipin antibodies with preeclampsia: A systematic review and meta-analysis. Obstet Gynecol 2010;116:1433-43. [Review]
29. Buyon JP, Clancy RM, Friedman DM. Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside. Nat Clin Pract Rheumatol 2009;5:139-48.
30. Kiuttu J, Hartifkainen-Sorri AL, Makitalo R. Occurrence of antinuclear antibodies in an unselected pregnancy population. Gynecol Obstet Invest 1992;33:21-5.
31. Weitgasser R, Spitzer D, Kartnig I, et al. Association of HELLP syndrome with autoimmune antibodies and glucose intolerance. Diabetes Care 2000;23:786-90.
32. Yamamoto T, Yoshimura S, Geshi Y, et al. Anti-ssDNA and dsDNA antibodies in preeclampsia. Asia-Oceania J Obstet Gynaecol 1994;20:93-9.
33. Ter Borg EJ, Horst G, Hummel EJ, et al. Measurement of increases in anti-double stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: A long-term, prospective study. Arthritis Rheum 1990;33:634-43.
34. To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum 2005;52:4003-10.
35. Clowse ME, Magder LS, Petri M. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. J Rheumatol 2011;38:1012-16.
36. Devoe LD, Loy GL. Serum complement levels and perinatal outcome in pregnancies complicated by systemic lupus erythematosus. Obstet Gynecol 1984;63:796-800.
37. Abramson SB, Buyon JP. Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy. Am J Reprod Immunol 1992;28:183-7.
38. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.